Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era88
Editorial introductions39
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV37
Strongyloidiasis-related lung involvement: too much of a bad thing37
From diagnosis to management: current perspectives on congenital cytomegalovirus infection35
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel31
Infection prevention measures in acute care settings based on severe acute respiratory syndrome coronavirus 2 transmission patterns and risk: a review30
Surgical management of cystic echinococcosis of the liver30
Complexities of cardiomyopathy in septic shock29
Corticosteroids for viral central nervous system infections29
Skin and soft tissue infections in the elderly28
La Crosse virus encephalitis in children28
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes27
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians27
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside26
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management25
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients24
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response24
Typhoid fever control in the 21st century: where are we now?24
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?23
Progress and challenges in human papillomavirus and cervical cancer in southern Africa23
New therapies for nontuberculous mycobacterial lung infection23
Fusarium species central nervous system infection23
Malaria in pregnancy: baby steps20
Mycobacterial skin infection20
Tuberculosis molecular bacterial load assay in the management of tuberculosis20
Mpox in people living with HIV20
Resistant herpes simplex virus infections – who, when, and what's new?20
Viral meningitis and encephalitis: an update20
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies19
Tick-borne encephalitis19
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention19
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli19
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?19
Using antibiotics wisely18
Multidrug-resistant, gram-negative infections in high-risk haematologic patients: an update on epidemiology, diagnosis and treatment18
Diagnostic stewardship: what impacts antibiotics use?18
Gut microbiome and its clinical implications: exploring the key players in human health17
Editorial introductions17
How coronavirus disease will change the face of travel medicine17
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis17
Does climate change threaten delivery of HIV care in resource-limited settings?16
Diagnostic approach and update on encephalitis16
CMV antiviral stewardship in transplantation – the next frontier16
Global health security as it pertains to Zika, Ebola, and COVID-1916
The impact of coronavirus disease 2019 on people with HIV15
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy15
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles15
Risk stratification for selecting empiric antibiotherapy during and after COVID-1915
Emerging treatment options for cryptosporidiosis15
Prevention strategies for congenital cytomegalovirus infection15
Appropriate surgical management in skin and soft tissue infections15
The microbiota in respiratory tract infections: from association to intervention14
Update on the treatment of chronic pulmonary aspergillosis14
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections13
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change13
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV13
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination13
Immunotherapeutic approaches to HIV cure and remission13
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1913
Childhood tuberculosis12
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential12
Editorial introductions12
Interpreting and managing preservation fluids positive for Gram-negative bacteria12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae12
Editorial: Pathogenesis and immune response – editorial12
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management12
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients11
Update on drug treatments for multidrug resistant tuberculosis11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans11
Respiratory metagenomics: route to routine service11
Short treatment duration for community-acquired pneumonia11
An overview of risk factors, management and prevention of cochlear implant infections11
The disease burden of respiratory syncytial virus in Infants10
The microbiome as a biomarker of anal precancerous lesions in people with HIV10
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis10
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?10
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives10
Identifying patients with difficult-to-treat acute bacterial skin infections10
Short-course antibiotic strategies for ventilator-associated pneumonia9
A new era of HIV care for age-associated multimorbidity9
Skin and soft tissue infections in solid organ transplants9
Burden of influenza in the elderly: a narrative review9
Novel techniques in the treatment of skin and soft tissue infection9
The role of Gram-negative bacteria in skin and soft tissue infections9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention9
Neurobrucellosis9
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens8
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice8
Editorial introductions8
Updates on the neurological manifestations of SARS-CoV-2 infection8
The evolution of knowledge for treating Gram-negative bacterial infections8
Editorial introductions8
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives8
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika8
Policy and planning for large epidemics and pandemics – challenges and lessons learned from COVID-198
Zoonoses and global epidemics8
Therapeutic agents for the treatment of human mpox8
Antibiotic treatment of acute bacterial skin and skin structure infections8
Chagas disease in the immunocompromised host8
Immune responses and severe dengue: what have we learned?8
Dose optimisation of antibiotics used for meningitis8
Surgical site infection prophylaxis: what have we learned and are we making progress?8
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach8
Staphylococcus aureus infections in children8
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity8
Editorial introductions8
New evidence for managing Gram-negative bloodstream infections8
0.063946008682251